Dr. Doured Daghistani explains how pediatric oncology is shifting toward reducing long-term side effects as childhood cancer survival rates rise.
Dr. Doured Daghistani
Advertisement
Articles by Dr. Doured Daghistani
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CURE
1
Breast Cancer Treatments Awaiting FDA Decisions: 4 to Watch
2
FDA Approves Etcamah Plus CDK4/6 Inhibitor for ESR1-Mutated Breast Cancer
3
How AI Is Changing Breast Cancer Screening
4
Prostate Cancer Treatments in the FDA Pipeline: What Could Come Next
5